vs
Side-by-side financial comparison of FIRST HORIZON CORP (FHN) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $888.0M, roughly 1.7× FIRST HORIZON CORP). FIRST HORIZON CORP runs the higher net margin — 29.4% vs -13.6%, a 43.0% gap on every dollar of revenue. On growth, FIRST HORIZON CORP posted the faster year-over-year revenue change (21.8% vs -5.3%). FIRST HORIZON CORP produced more free cash flow last quarter ($389.0M vs $96.0M). Over the past eight quarters, FIRST HORIZON CORP's revenue compounded faster (20.0% CAGR vs -3.6%).
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
FHN vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $888.0M | $1.5B |
| Net Profit | $261.0M | $-205.0M |
| Gross Margin | — | 49.2% |
| Operating Margin | 38.5% | -9.8% |
| Net Margin | 29.4% | -13.6% |
| Revenue YoY | 21.8% | -5.3% |
| Net Profit YoY | 57.2% | -288.1% |
| EPS (diluted) | $0.51 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $888.0M | $1.5B | ||
| Q3 25 | $889.0M | $1.6B | ||
| Q2 25 | $830.0M | $1.6B | ||
| Q1 25 | $812.0M | $1.5B | ||
| Q4 24 | $729.0M | $1.6B | ||
| Q3 24 | $827.0M | $1.6B | ||
| Q2 24 | — | $1.6B | ||
| Q1 24 | $819.0M | $1.6B |
| Q4 25 | $261.0M | $-205.0M | ||
| Q3 25 | $262.0M | $160.0M | ||
| Q2 25 | $241.0M | $145.0M | ||
| Q1 25 | $218.0M | $87.0M | ||
| Q4 24 | $166.0M | $109.0M | ||
| Q3 24 | $218.0M | $359.0M | ||
| Q2 24 | — | $195.0M | ||
| Q1 24 | $192.0M | $201.0M |
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
| Q4 25 | 38.5% | -9.8% | ||
| Q3 25 | 38.7% | 15.2% | ||
| Q2 25 | 37.2% | 14.4% | ||
| Q1 25 | 35.1% | 6.7% | ||
| Q4 24 | 28.8% | 8.1% | ||
| Q3 24 | 34.0% | 13.1% | ||
| Q2 24 | — | 14.6% | ||
| Q1 24 | 31.0% | 14.5% |
| Q4 25 | 29.4% | -13.6% | ||
| Q3 25 | 29.5% | 10.0% | ||
| Q2 25 | 29.0% | 9.1% | ||
| Q1 25 | 26.8% | 5.8% | ||
| Q4 24 | 22.8% | 6.8% | ||
| Q3 24 | 26.4% | 22.7% | ||
| Q2 24 | — | 12.1% | ||
| Q1 24 | 23.4% | 12.4% |
| Q4 25 | $0.51 | $-0.78 | ||
| Q3 25 | $0.50 | $0.61 | ||
| Q2 25 | $0.45 | $0.56 | ||
| Q1 25 | $0.41 | $0.33 | ||
| Q4 24 | $0.29 | $0.42 | ||
| Q3 24 | $0.40 | $1.38 | ||
| Q2 24 | — | $0.75 | ||
| Q1 24 | $0.33 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $574.0M |
| Total DebtLower is stronger | — | $8.6B |
| Stockholders' EquityBook value | $8.8B | $752.0M |
| Total Assets | $83.9B | $12.9B |
| Debt / EquityLower = less leverage | — | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $574.0M | ||
| Q3 25 | — | $672.0M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $547.0M | ||
| Q4 24 | — | $675.0M | ||
| Q3 24 | — | $763.0M | ||
| Q2 24 | — | $704.0M | ||
| Q1 24 | — | $575.0M |
| Q4 25 | — | $8.6B | ||
| Q3 25 | — | $8.8B | ||
| Q2 25 | — | $8.9B | ||
| Q1 25 | — | $9.0B | ||
| Q4 24 | — | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $8.8B | $752.0M | ||
| Q3 25 | $8.9B | $906.0M | ||
| Q2 25 | $9.0B | $733.0M | ||
| Q1 25 | $8.7B | $542.0M | ||
| Q4 24 | $8.8B | $472.0M | ||
| Q3 24 | $9.0B | $493.0M | ||
| Q2 24 | — | $144.0M | ||
| Q1 24 | $8.9B | $48.0M |
| Q4 25 | $83.9B | $12.9B | ||
| Q3 25 | $83.2B | $13.6B | ||
| Q2 25 | $82.1B | $13.5B | ||
| Q1 25 | $81.5B | $13.2B | ||
| Q4 24 | $82.2B | $13.1B | ||
| Q3 24 | $82.6B | $12.8B | ||
| Q2 24 | — | $12.2B | ||
| Q1 24 | $81.8B | $11.9B |
| Q4 25 | — | 11.49× | ||
| Q3 25 | — | 9.74× | ||
| Q2 25 | — | 12.14× | ||
| Q1 25 | — | 16.52× | ||
| Q4 24 | — | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $396.0M | $141.0M |
| Free Cash FlowOCF − Capex | $389.0M | $96.0M |
| FCF MarginFCF / Revenue | 43.8% | 6.4% |
| Capex IntensityCapex / Revenue | 0.8% | 3.0% |
| Cash ConversionOCF / Net Profit | 1.52× | — |
| TTM Free Cash FlowTrailing 4 quarters | $595.0M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $396.0M | $141.0M | ||
| Q3 25 | $-200.0M | $264.0M | ||
| Q2 25 | $83.0M | $220.0M | ||
| Q1 25 | $349.0M | $75.0M | ||
| Q4 24 | $191.0M | $390.0M | ||
| Q3 24 | $389.0M | $141.0M | ||
| Q2 24 | — | $332.0M | ||
| Q1 24 | $838.0M | $76.0M |
| Q4 25 | $389.0M | $96.0M | ||
| Q3 25 | $-208.0M | $218.0M | ||
| Q2 25 | $74.0M | $181.0M | ||
| Q1 25 | $340.0M | $43.0M | ||
| Q4 24 | $174.0M | $335.0M | ||
| Q3 24 | $383.0M | $99.0M | ||
| Q2 24 | — | $300.0M | ||
| Q1 24 | $828.0M | $30.0M |
| Q4 25 | 43.8% | 6.4% | ||
| Q3 25 | -23.4% | 13.6% | ||
| Q2 25 | 8.9% | 11.4% | ||
| Q1 25 | 41.9% | 2.8% | ||
| Q4 24 | 23.9% | 21.0% | ||
| Q3 24 | 46.3% | 6.3% | ||
| Q2 24 | — | 18.7% | ||
| Q1 24 | 101.1% | 1.8% |
| Q4 25 | 0.8% | 3.0% | ||
| Q3 25 | 0.9% | 2.9% | ||
| Q2 25 | 1.1% | 2.4% | ||
| Q1 25 | 1.1% | 2.1% | ||
| Q4 24 | 2.3% | 3.5% | ||
| Q3 24 | 0.7% | 2.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | 1.2% | 2.8% |
| Q4 25 | 1.52× | — | ||
| Q3 25 | -0.76× | 1.65× | ||
| Q2 25 | 0.34× | 1.52× | ||
| Q1 25 | 1.60× | 0.86× | ||
| Q4 24 | 1.15× | 3.58× | ||
| Q3 24 | 1.78× | 0.39× | ||
| Q2 24 | — | 1.70× | ||
| Q1 24 | 4.36× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHN
| Commercial Consumer And Wealth Segment | $776.0M | 87% |
| Other | $88.0M | 10% |
| Corporate | $24.0M | 3% |
OGN
Segment breakdown not available.
